Search | IOVS | ARVO Journals

Showing 1 – 20 of 80

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Cornea February 2025

Climate Determinants of Keratoconus: Insights From a Systematic Review of Prevalence

PDF

Hasan Shabani; Job De Ridder; Mohammad Ali Asaad; Wichor M. Bramer; Magda A. Meester-Smoor; Annette A. J. M. Geerards; Caroline C. W. Klaver; Wishal D. Ramdas; Bart T. H. van Dooren
TAGS: climate, keratoconus, prevalence, systematic reviews
Invest. Ophthalmol. Vis. Sci.. 2025; 66(2):30. https://doi.org/10.1167/iovs.66.2.30

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Structural OCT biomarkers, trends, and early detection in fellow eyes of patients receiving Intravitreal injections for neovascular age-related macular degeneration (nAMD) over a 5-year period.

Sneha Melmane; Savithri Sreekala; Lekshmi Thankachan; Harbhajan Arora; Geeta Menon; Karima Nesnas; Manju Chandran

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):239.

ARVO Annual Meeting Abstract June 2024

A Prospective study of type 1 and type 2 Diabetics examining the correlation between antioxidant levels and neuronal layer loss. (DECAN study)

LORRAINE NORTH; Manju Chandran; Geeta Menon; Narendran Nair

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):868.

ARVO Annual Meeting Abstract June 2024

Real-world evidence of biosimilar Ranibizumab in management of neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macula oedema (DMO): Switches and treatment naive.

Petya Simeonova Ford; Geeta Menon; Sneha Melmane; Amy Mohan; Karima Nesnas; Lorraine North; Narendran Nair; Manju Chandran

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):243.

ARVO Annual Meeting Abstract June 2024

Ten-Year -Real World Outcome (RWO) of Anti Vascular Endothelial Growth Factor Therapy(Anti VEGF)in Diabetic MAcular Oedema(DMO).

Sely Mathew; Manju Chandran; Harbhajan Arora; Geeta Menon; narendran nair; aarthy Jeganathen; Mohamed Elsaeed; Amy Mohan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3214.

ARVO Annual Meeting Abstract June 2024

Vascular and non-vascular predictors of long-term visual field progression in the Leuven Eye Study.

Jan Van Eijgen; João Barbosa-Breda; Margaux Delporte; Dries De Witte; Amandio A Rocha-Sousa; Evelien Vandewalle; Luis Abegão-Pinto; Geert Molenberghs; Ingeborg Stalmans

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4803.

ARVO Annual Meeting Abstract June 2024

Towards automated optical coherence tomography (OCT) data analysis for a real-world diabetic macular edema (DME) treatment cohort

James Talks; Tunde Peto; Xiaoyong Wang; Anda Gershon; Geeta Menon; Faruque Ghanchi; Xin Chen; Vivian Look; Huanxiang Lu; Michael H. Chen; Daniela Ferrara; Gloria Chi; Qi Yang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5956.

ARVO Annual Meeting Abstract June 2024

Real-world evidence of Faricimab in management of Neovascular Age related Macular Degeneration (nAMD) and Diabetic Macular Oedema (DMO) : Treatment Naïve and Suboptimal Responders.

Savithri Sreekala; Sneha Melmane; Mohamed Elsaeed; Harbhajan Arora; Manju Chandran; Geeta Menon

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6122.

Cornea September 2023

Isolation and Characterization of Human Conjunctival Mesenchymal Stromal Cells and Their Extracellular Vesicles

PDF

Laura García-Posadas; Ismael Romero-Castillo; Kieran Brennan; Margaret M. Mc Gee; Alfonso Blanco-Fernández; Yolanda Diebold
TAGS: antioxidants, conjunctiva, extracellular vesicles, mesenchymal stem cells, patient isolation, social isolation, body tissue, flow cytometry, conjunctival epithelial cells
Invest. Ophthalmol. Vis. Sci.. 2023; 64(12):38. https://doi.org/10.1167/iovs.64.12.38

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Ten Year Real World Outcome of Anti-Vascular Endothelial Growth Factor therapy in Neovascular Age-Related Macular Degeneration

Sneha Melmane; Savithri Sreekala; Manju Chandran; Geeta Menon; Sowjanya Yerramsetti

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2220.

ARVO Annual Meeting Abstract June 2023

Diabetic macular edema 5-year outcomes: a multicenter analysis

Tunde Peto; James Talks; Geeta Menon; Faruque Ghanchi; Xin Chen; Qi Yang; Daniela Ferrara; Luyi Adesanye; Gloria C Chi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2650.

ARVO Annual Meeting Abstract June 2023

6-year outcomes of the United Kingdom Medisoft® audit study following treatment with the ILUVIEN® (fluocinolone acetonide) implant in patients with diabetic macular edema.

Bushra Mushtaq; Clare C Bailey; Usha Chakravarthy; Andrew J Lotery; James Talks; Geeta Menon

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2651.

ARVO Annual Meeting Abstract June 2022

Plaque Brachytherapy Outcomes for Large Choroidal Melanomas

Emily Xi Liao; Jordan Huang; Aqsa Saleem; Matthew Laroque; Geetha Menon; Albert Murtha; Paige Campbell; Ezekiel Weis

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2363 – A0032.

Genetics August 2021

Phenotypic Consequences of the GJD2 Risk Genotype in Myopia Development

PDF

Annechien E. G. Haarman; Clair A. Enthoven; Milly S. Tedja; Jan R. Polling; J. Willem L. Tideman; Jan E. E. Keunen; Camiel J. F. Boon; Janine F. Felix; H. Raat; Annette J. M. Geerards; Gregorius P. M. Luyten; Gwyneth A. van Rijn; Virginie J. M. Verhoeven; Caroline C. W. Klaver
TAGS: adult, genes, genotype, myopia, phenotype, child, refractive errors, biometry
Invest. Ophthalmol. Vis. Sci.. 2021; 62(10):16. https://doi.org/10.1167/iovs.62.10.16

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Defective DNA Repair in Fuchs endothelial corneal dystrophy

Neha Deshpande; Geetha Melangath; Shivakumar Vasanth; Marianne Price; Francis Price; Ula V Jurkunas

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):838.

ARVO Annual Meeting Abstract June 2021

A Prospective study of type 1 and type 2 Diabetics examining the correlation between antioxidant levels and neuronal layer loss. (DECAN study)- An exploratory Study

LORRAINE NORTH; Geeta V Menon; Manju Chandran

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1103.

ARVO Annual Meeting Abstract June 2021

Safety of multiple intravitreal injections of ocriplasmin in subjects with non–proliferative diabetic retinopathy (NPDR): Results of the CIRCLE study.

Mahi Muqit; Ramin Tadayoni; J Hamouz; Victor H Gonzalez; Javier Montero; David Scales; Geeta V Menon; Prema Abraham; Timothy L Jackson; Ivan Fiser; Petra Kozma-Wiebe

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1083.

ARVO Annual Meeting Abstract June 2020

Increased corneal endothelial cell migration in Fuchs endothelial corneal dystrophy, with or without TCF4 repeat expansion

Stephan Ong Tone; Adam Wylegala; Myriam Susanne Boehm; Geetha Melangath; Ula Jurkunas

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1188.

ARVO Annual Meeting Abstract June 2020

Loss of NQO1 exacerbates female susceptibility to the development of Fuchs dystrophy in response to ultraviolet light.

Varun Kumar; Neha Deshpande; Geetha Melangath; Hanna Hui; Shan Zhu; Ula Jurkunas

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1470.

ARVO Annual Meeting Abstract June 2020

Deregulation of mitochondrial DNA repair genes in Fuchs Endothelial Corneal Dystrophy

Geetha Melangath; Shivakumar Vasanth; Neha Deshpande; Varun Kumar; Marianne Price; Francis Price Jr.; Ula Jurkunas

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1471.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Climate Determinants of Keratoconus: Insights From a Systematic Review of Prevalence

Structural OCT biomarkers, trends, and early detection in fellow eyes of patients receiving Intravitreal injections for neovascular age-related macular degeneration (nAMD) over a 5-year period.

A Prospective study of type 1 and type 2 Diabetics examining the correlation between antioxidant levels and neuronal layer loss. (DECAN study)

Real-world evidence of biosimilar Ranibizumab in management of neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macula oedema (DMO): Switches and treatment naive.

Ten-Year -Real World Outcome (RWO) of Anti Vascular Endothelial Growth Factor Therapy(Anti VEGF)in Diabetic MAcular Oedema(DMO).

Vascular and non-vascular predictors of long-term visual field progression in the Leuven Eye Study.

Towards automated optical coherence tomography (OCT) data analysis for a real-world diabetic macular edema (DME) treatment cohort

Real-world evidence of Faricimab in management of Neovascular Age related Macular Degeneration (nAMD) and Diabetic Macular Oedema (DMO) : Treatment Naïve and Suboptimal Responders.

Isolation and Characterization of Human Conjunctival Mesenchymal Stromal Cells and Their Extracellular Vesicles

Ten Year Real World Outcome of Anti-Vascular Endothelial Growth Factor therapy in Neovascular Age-Related Macular Degeneration

Diabetic macular edema 5-year outcomes: a multicenter analysis

6-year outcomes of the United Kingdom Medisoft® audit study following treatment with the ILUVIEN® (fluocinolone acetonide) implant in patients with diabetic macular edema.

Plaque Brachytherapy Outcomes for Large Choroidal Melanomas

Phenotypic Consequences of the GJD2 Risk Genotype in Myopia Development

Defective DNA Repair in Fuchs endothelial corneal dystrophy

A Prospective study of type 1 and type 2 Diabetics examining the correlation between antioxidant levels and neuronal layer loss. (DECAN study)- An exploratory Study

Safety of multiple intravitreal injections of ocriplasmin in subjects with non–proliferative diabetic retinopathy (NPDR): Results of the CIRCLE study.

Increased corneal endothelial cell migration in Fuchs endothelial corneal dystrophy, with or without TCF4 repeat expansion

Loss of NQO1 exacerbates female susceptibility to the development of Fuchs dystrophy in response to ultraviolet light.

Deregulation of mitochondrial DNA repair genes in Fuchs Endothelial Corneal Dystrophy

To View More...

You must be signed into an individual account to use this feature.